{"id":"W4224529699","doi":"10.1016/s2352-3026(22)00045-x","title":"Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies","year":2022,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; Princess Margaret Cancer Centre","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute; Genentech; Center for Clinical and Translational Science, Mayo Clinic; U.S. Food and Drug Administration; Medac; Swedish Orphan Biovitrum; Daiichi-Sankyo; Energy Market Authority of Singapore; Pfizer; Incyte; Yorkshire Cancer Research; Bayer Fund; TG Therapeutics; MorphoSys; UCB; National Institutes of Health; Regeneron Pharmaceuticals; Breast Cancer Now; Kræftens Bekæmpelse; Takeda Pharmaceuticals U.S.A.; Novartis; Celgene; Alnylam Pharmaceuticals; Sanofi; National Center for Advancing Translational Sciences; Teva Pharmaceutical Industries; Astellas Pharma; Georgia Clinical and Translational Science Alliance; GlaxoSmithKline; Boehringer Ingelheim; Amgen; Bristol-Myers Squibb; Roche; Astellas Pharma US; Daiichi Sankyo Europe; National Cancer Institute; Servier; Gilead Sciences","keywords":"Adverse effect; Context (archaeology); Clinical trial; Cancer; Hematology; Patient safety","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001579675,0.0001325262,0.0008324272,0.0000634413,0.0003709258,0.000003111957,0.0001183455,0.00008395989,0.00001088675],"category_scores_gemma":[0.0001468442,0.00007832192,0.00006395819,0.0001533326,0.0002376694,0.00003573863,0.0001617011,0.000505992,7.176804e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005768776,"about_ca_system_score_gemma":0.00005145247,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000267801,"about_ca_topic_score_gemma":0.00003232496,"domain_scores_codex":[0.9983788,0.000271365,0.0006478702,0.0002567823,0.0001704821,0.0002747216],"domain_scores_gemma":[0.9986304,0.0003189369,0.0006809962,0.0003069247,0.00003202225,0.00003072608],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005585319,0.0003579846,0.9644004,0.0006333194,0.0002097897,0.0003427489,0.008617945,0.00007712601,0.002160186,0.01562857,0.0002578175,0.006755622],"study_design_scores_gemma":[0.009846047,0.0007383064,0.810536,0.0004744459,0.0005685732,0.04840452,0.01443593,0.01311224,0.002708736,0.08924947,0.009342477,0.0005832768],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9716533,0.001838269,0.0002295255,0.02506686,0.000143813,0.0008687505,0.00001055221,0.00004155891,0.0001473118],"genre_scores_gemma":[0.9956732,0.0001907178,0.003407452,0.0004048402,0.00007401554,0.0002041877,0.000008912255,0.00001693082,0.00001972831],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1538644,"threshold_uncertainty_score":0.3193875,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06402545302891255,"score_gpt":0.3630694404143654,"score_spread":0.2990439873854528,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}